Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

The Prognostic Value for Survival of Self-Reported Fatigue in Patients with Newly Diagnosed Myelodysplastic Syndromes: An International Prospective Observational Study By the Gimema

Blood (2024) 144 (Supplement 1): 404.

https://doi.org/10.1182/blood-2024-204633

Published: 2024

Journal Articles

Silk Bone Marrow-like Niches for Red Cell Production Ex Vivo

Christian A Di Buduo, Virginia Camilotto, Francesca Careddu, Marco Lunghi, Rosangela Invernizzi, Claudia Del Fante, Luca Malcovati, Alessandra Balduini

Blood (2022) 140 (Supplement 1): 2427–2428.

https://doi.org/10.1182/blood-2022-169655

Published: 2022

Journal Articles

Pretreatment Health-Related Quality of Life Profile According to the EORTC QLQ-C30 in Patients with Myelodysplastic Syndromes (MDS): Analysis on 443 Lower-Risk MDS Patients

Blood (2018) 132 (Supplement 1): 2293.

https://doi.org/10.1182/blood-2018-99-110921

Published: 2018

Journal Articles

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Maria Ilaria Del Principe, Roberta di Blasi, MD, Luisa Verga, MD, Anna Candoni, MD, Stelvio Ballanti, MD, Leonardo Potenza, Chiara Cattaneo, MD, Mario Delia, MD, Nunzia Decembrino, MD, Lorella MA Melillo, MD, Carlo Castagnola, MD, Gianpaolo Nadali, MD, Rosa Fanci, MD, Antonella Ferrari, MD, Nicola Fracchiolla, MD, Enrico Orciuolo, PhD MD, Federica Lessi, MD, Anna Chierichini, MD, Massimo Offidani, MD, Marco Picardi, MD, Lucia Prezioso, MD, Benedetta Rambaldi, MD, Francesco Marchesi, MD, Ombretta Annibali, Daniele Zama, MD, Valentina Mancini, MD, Prassede Salutari, MD, Maria Grazia Garzia, MD, Adriana Vacca, MD, Simone Cesaro, MD, Rosangela Invernizzi, MD, Katia Perruccio, MD, Maria Enza Mitra, MD, Angela Maria Quinto, MD, Maria Chiara Tisi, Bruno Martino, Adriano Venditti, MD, Alessandro Busca, Franco Aversa, MD, Livio Pagano, MD

Blood (2017) 130 (Supplement 1): 5018.

https://doi.org/10.1182/blood.V130.Suppl_1.5018.5018

Published: 2017

Journal Articles

Impact of Transfusion Dependency on Health-Related Quality of Life Outcomes in Newly Diagnosed Patients with Myelodysplastic Syndromes (MDS). Analysis on 669 Patients By Disease Risk

Blood (2017) 130 (Supplement 1): 353.

https://doi.org/10.1182/blood.V130.Suppl_1.353.353

Published: 2017

Journal Articles

Inclusion of Patient's Self-Reported Fatigue into a Standard Laboratory Risk Classification Enhances Survival Prediction in Patients with Advanced Myelodysplastic Syndromes

Blood (2016) 128 (22): 1242.

https://doi.org/10.1182/blood.V128.22.1242.1242

Published: 2016

Journal Articles

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Blood (2015) 126 (2): 233–241.

https://doi.org/10.1182/blood-2015-03-633537

Published: 2015

Includes: Supplemental data

Journal Articles

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2014) 124 (21): 825.

https://doi.org/10.1182/blood.V124.21.825.825

Published: 2014

Journal Articles

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Blood (2014) 124 (9): 1513–1521.

https://doi.org/10.1182/blood-2014-03-560227

Published: 2014

Includes: Supplemental data

Journal Articles

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Ilaria Ambaglio, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Chiara Elena, MD, Marta Ubezio, MD, Elisa Bono, MD, Matteo C Da Vià, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 2755.

https://doi.org/10.1182/blood.V122.21.2755.2755

Published: 2013

Journal Articles

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Blood (2013) 122 (21): 2659.

https://doi.org/10.1182/blood.V122.21.2659.2659

Published: 2013

Journal Articles

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Chiara Elena, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Ilaria Ambaglio, MD, Marta Ubezio, MD, Matteo C Da Vià, MD, Elisa Bono, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1532.

https://doi.org/10.1182/blood.V122.21.1532.1532

Published: 2013

Journal Articles

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Ilaria Ambaglio, Anna Gallì, Daniela Pietra, Matteo G Della Porta, Marta Ubezio, Matteo C Da Vià, Elisa Bono, Chiara Milanesi, Erica Travaglino, Rosangela Invernizzi, Elli Papaemmanuil, Peter Campbell, Luca Malcovati, Mario Cazzola

Blood (2012) 120 (21): 172.

https://doi.org/10.1182/blood.V120.21.172.172

Published: 2012

Journal Articles

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

Carlo L Balduini, Francesca Bellistri, Fabio Pagella, Francesco Chu, Elina Matti, Giuseppe Spinozzi, Federica Ornati, Cecilia Canzonieri, Carla Olivieri, Cesare Danesino, Marco Benazzo, Rosangela Invernizzi

Blood (2012) 120 (21): 629.

https://doi.org/10.1182/blood.V120.21.629.629

Published: 2012

Journal Articles

The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44

Vittorio Perfetti, Giovanni Palladini, Simona Casarini, Valentina Navazza, Paola Rognoni, Laura Obici, Rosangela Invernizzi, Stefano Perlini, Catherine Klersy, Giampaolo Merlini

Blood (2012) 119 (1): 144–150.

https://doi.org/10.1182/blood-2011-05-355784

Published: 2012

Journal Articles

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

Giovanni Palladini, MD, PhD, Paola Russo, MD, Paolo Milani, MD, Andrea Foli, MD, Letizia Zenone Bragotti, MD, Laura Obici, MD, Francesca Lavatelli, MD, Silvia Brugnatelli, MD, Vittorio Perfetti, MD, PhD, Rosangela Invernizzi, MD, Giampaolo Merlini, MD

Blood (2010) 116 (21): 3062.

https://doi.org/10.1182/blood.V116.21.3062.3062

Published: 2010

Journal Articles

Mutational Status of TET2 , JAK2 , and MPL in Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis.

Luca Malcovati, Angela Brisci, Daniela Pietra, Matteo G Della Porta, Anna Gallífi, Francesca Bruno, Erica Travaglino, Sabrina Boggi, Elisa Rumi, Francesco Passamonti, Maurizio Ferrari, Rosangela Invernizzi, Laura Cremonesi, Mario Cazzola

Blood (2009) 114 (22): 418.

https://doi.org/10.1182/blood.V114.22.418.418

Published: 2009

Journal Articles

The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis.

Matteo G Della Porta, Vittorio Rosti, Anna Gallì, Erica Travaglino, Paolo Santambrogio, Carmela Marseglia, Valentina Matti, Luca Malcovati, Gaetano Bergamaschi, Sonia Levi, Rosangela Invernizzi, Mario Cazzola

Blood (2009) 114 (22): 736.

https://doi.org/10.1182/blood.V114.22.736.736

Published: 2009

Journal Articles

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

Luca Malcovati, Matteo G. Della Porta, Daniela Pietra, Emanuela Boveri, Andrea Pellagatti, Anna Gallì, Erica Travaglino, Angela Brisci, Elisa Rumi, Francesco Passamonti, Rosangela Invernizzi, Laura Cremonesi, Jacqueline Boultwood, James S. Wainscoat, Eva Hellström-Lindberg, Mario Cazzola

Blood (2009) 114 (17): 3538–3545.

https://doi.org/10.1182/blood-2009-05-222331

Published: 2009

Journal Articles

Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome

Luca Malcovati, MD, Matteo G Della Porta, MD, Coby M Laarakkers, MD, Anna Gallì, BSc, Riccardo Albertini, MD, Margherita Maffioli, MD, Ilaria Ambaglio, MD, Erica Travaglino, Rosangela Invernizzi, MD, Remigio Moratti, MD, Dorine W. Swinkels, MD, PhD, Mario Cazzola, MD

Blood (2008) 112 (11): 2676.

https://doi.org/10.1182/blood.V112.11.2676.2676

Published: 2008

NARROW

The Prognostic Value for Survival of Self-Reported Fatigue in Patients with Newly Diagnosed Myelodysplastic Syndromes: An International Prospective Observational Study By the Gimema

Silk Bone Marrow-like Niches for Red Cell Production Ex Vivo

Pretreatment Health-Related Quality of Life Profile According to the EORTC QLQ-C30 in Patients with Myelodysplastic Syndromes (MDS): Analysis on 443 Lower-Risk MDS Patients

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Impact of Transfusion Dependency on Health-Related Quality of Life Outcomes in Newly Diagnosed Patients with Myelodysplastic Syndromes (MDS). Analysis on 669 Patients By Disease Risk

Inclusion of Patient's Self-Reported Fatigue into a Standard Laboratory Risk Classification Enhances Survival Prediction in Patients with Advanced Myelodysplastic Syndromes

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

Mutational Status of TET2 , JAK2 , and MPL in Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis.

The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis.

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only